© Copyright - Newspaper WordPress Theme by TagDiv
Norethisterone
Also known as / Synonyms: Norethindrone, 19-Nor-17alpha-ethynyltestosterone, Progestin
Synthetic progestin tablet used to postpone periods, stop heavy uterine bleeding, and treat endometriosis pain.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Dysfunctional uterine bleeding (DUB) and menorrhagia (heavy menstrual bleeding).
- Postponement/delay of menstruation for travel, religious observances, or surgical procedures.
- Endometriosis and adenomyosis (suppressive therapy to alleviate chronic pelvic pain).
- Secondary amenorrhea and oligomenorrhea (progestin challenge test).
- Premenstrual syndrome (PMS) and premenstrual dysphoric disorder.
Contraindications (Do Not Use If…)
- Known or suspected pregnancy (teratogenic risk).
- Active or past history of venous thromboembolism (deep vein thrombosis, pulmonary embolism) or arterial thromboembolism (stroke, myocardial infarction).
- Undiagnosed abnormal vaginal bleeding.
- Severe hepatic impairment, active liver disease, or hepatic adenomas.
- Known or suspected hormone-sensitive breast cancer or genital tract malignancies.
- Porphyria.
Important Clinical Precautions & Warnings
- Thromboembolic risk: synthetic progestins partially metabolize to ethinylestradiol and increase venous thromboembolism risk; discontinue immediately if symptoms of DVT, pulmonary embolism, or sudden visual disturbances occur.
- Protocol for postponement of menses: take 5 mg three times daily starting at least 3 days before the expected onset of menstruation; menses will typically occur 2 to 3 days after stopping the tablets.
- Not a contraceptive: 5 mg norethisterone regimens do not guarantee contraceptive protection; patients must use non-hormonal barrier contraception.
- Fluid retention and hypertension: can cause fluid retention; use with caution in patients with cardiac failure, hypertension, or renal dysfunction.
- Depression and mood changes: monitor patients with a history of clinical depression; discontinue if severe depression recurs.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Indicated only after menarche; safety in premenarchal girls not established. Geriatric: Not indicated in postmenopausal women.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Breakthrough bleeding, spotting, amenorrhea, nausea, headache, breast tenderness, weight gain, bloating, and acne.
Serious Side Effects — Seek Urgent Medical Care
Deep vein thrombosis (DVT), pulmonary embolism, ischemic stroke, cholestatic jaundice, severe migraine headache, and anaphylactoid reactions.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Hepatic enzyme inducers (rifampin, carbamazepine, phenytoin, St. John's wort): accelerate hepatic clearance of norethisterone, leading to reduced efficacy and breakthrough bleeding.
- Anticoagulants: progestins may alter anticoagulant requirements; monitor INR.
- Cyclosporine: progestins can inhibit cyclosporine metabolism, increasing toxicity risk.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Contraindicated during pregnancy. First-trimester exposure to synthetic 19-norsteroids has been associated with masculinization of external genitalia in female fetuses. A pregnancy test must confirm non-pregnant status before initiating therapy.
Lactation & Breastfeeding:
Use with caution — see notesSmall amounts of progestins pass into human breast milk. While low-dose progestin-only pills are acceptable during lactation, high-dose 5 mg norethisterone may decrease milk production. Use with medical guidance.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store tablets below 25°C (77°F). Protect from light and moisture.
⏱️ Missed Dose Protocol:
Take the missed dose as soon as remembered. If close to the next scheduled dose, skip and resume regular schedule. Breakthrough bleeding may occur following a missed dose.
Acute overdose produces nausea, vomiting, breast enlargement, and vaginal bleeding upon withdrawal. Supportive care is advised; serious toxicity is uncommon.
